Currenc Group, Inc. (CURR)

USD 1.41

(-0.28%)

Operating Income Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual operating income in 2023 was -6.64 Million USD , up 63.62% from previous year.
  • Currenc Group, Inc.'s latest quarterly operating income in 2024 Q2 was -715 Thousand USD , up 49.67% from previous quarter.
  • Currenc Group, Inc. reported an annual operating income of -18.27 Million USD in 2022, down -8.32% from previous year.
  • Currenc Group, Inc. reported an annual operating income of -16.86 Million USD in 2021, down -27.98% from previous year.
  • Currenc Group, Inc. reported a quarterly operating income of -1.42 Million USD for 2024 Q1, down -126.29% from previous quarter.
  • Currenc Group, Inc. reported a quarterly operating income of -1.49 Million USD for 2023 Q2, up 11.16% from previous quarter.

Annual Operating Income Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Operating Income of Currenc Group, Inc. (2023 - 2014)

Year Operating Income Operating Income Growth
2023 -6.64 Million USD 63.62%
2022 -18.27 Million USD -8.32%
2021 -16.86 Million USD -27.98%
2020 -13.17 Million USD -9.51%
2019 -12.03 Million USD -59.24%
2018 -7.55 Million USD -2.94%
2017 -7.34 Million USD -87.0%
2016 -3.92 Million USD -155.69%
2015 -1.53 Million USD -104.82%
2014 -749.68 Thousand USD 0.0%

Peer Operating Income Comparison of Currenc Group, Inc.

Name Operating Income Operating Income Difference
ANI Pharmaceuticals, Inc. 46.97 Million USD 114.149%
Aquestive Therapeutics, Inc. -15.1 Million USD 55.994%
Collegium Pharmaceutical, Inc. 166.96 Million USD 103.98%
Cosmos Health Inc. -21.83 Million USD 69.558%
Cyclo Therapeutics, Inc. -20.05 Million USD 66.854%
Esperion Therapeutics, Inc. -155.56 Million USD 95.728%
Cronos Group Inc. -81.37 Million USD 91.833%
Incannex Healthcare Limited -30.04 Million USD 77.878%
Kala Pharmaceuticals, Inc. -39.15 Million USD 83.026%
Lifecore Biomedical, Inc. 9.33 Million USD 171.223%
Regencell Bioscience Holdings Limited -4.73 Million USD -40.303%
Sunshine Biopharma, Inc. -4.78 Million USD -38.879%
Sunshine Biopharma, Inc. -4.78 Million USD -38.879%
SCYNEXIS, Inc. 72.66 Million USD 109.145%
Safety Shot Inc -12.18 Million USD 45.455%
Theratechnologies Inc. -10.62 Million USD 37.463%
Alpha Teknova, Inc. -35.56 Million USD 81.313%
Universe Pharmaceuticals INC -3.52 Million USD -88.438%
Pacira BioSciences, Inc. 87.67 Million USD 107.58%
Sonoma Pharmaceuticals, Inc. -4.7 Million USD -41.37%
Dynavax Technologies Corporation -37.02 Million USD 82.052%
Ironwood Pharmaceuticals, Inc. 209.03 Million USD 103.179%
Radius Health, Inc. -3.92 Million USD -69.319%
China SXT Pharmaceuticals, Inc. -2.51 Million USD -164.223%
Alvotech -354.86 Million USD 98.127%
Intra-Cellular Therapies, Inc. -159.38 Million USD 95.83%
SIGA Technologies, Inc. 83.62 Million USD 107.947%
Shineco, Inc. -17.06 Million USD 61.058%
Silver Spike Investment Corp. 7.34 Million USD 190.541%
Journey Medical Corporation -2.07 Million USD -220.588%
Petros Pharmaceuticals, Inc. -13.61 Million USD 51.196%
Embecta Corp. 221.5 Million USD 103.0%
Harrow Health, Inc. 580 Thousand USD 1245.825%
Procaps Group, S.A. 38.97 Million USD 117.052%
Biofrontera Inc. -22.67 Million USD 70.694%
DURECT Corporation -36.88 Million USD 81.982%
PainReform Ltd. -9.58 Million USD 30.658%
Supernus Pharmaceuticals, Inc. -5.26 Million USD -26.13%
OptiNose, Inc. -22.74 Million USD 70.785%
RedHill Biopharma Ltd. 12.63 Million USD 152.611%
Organogenesis Holdings Inc. 12.52 Million USD 153.06%
Cumberland Pharmaceuticals Inc. -6.21 Million USD -7.003%
ProPhase Labs, Inc. -21.61 Million USD 69.251%
Phibro Animal Health Corporation 53.31 Million USD 112.465%
Procaps Group S.A. 52.32 Million USD 112.701%
TherapeuticsMD, Inc. -8.52 Million USD 22.025%
Viatris Inc. 766.2 Million USD 100.867%
Rockwell Medical, Inc. -6.67 Million USD 0.363%
Aytu BioPharma, Inc. -5.25 Million USD -26.49%
Tilray Brands, Inc. -174.74 Million USD 96.197%
PetIQ, Inc. 60.01 Million USD 111.074%
Talphera, Inc. -16.88 Million USD 60.65%
Neurocrine Biosciences, Inc. 250.9 Million USD 102.649%
Alimera Sciences, Inc. -1.47 Million USD -351.787%
Assertio Holdings, Inc. -243.53 Million USD 97.271%
Shuttle Pharmaceuticals Holdings, Inc. -5.89 Million USD -12.786%
Avadel Pharmaceuticals plc -137.84 Million USD 95.179%
Hempacco Co., Inc. -8.81 Million USD 24.585%
Alvotech -354.86 Million USD 98.127%
Lantheus Holdings, Inc. 364.64 Million USD 101.823%
Kamada Ltd. 10.06 Million USD 166.035%
Indivior PLC -4 Million USD -66.145%
Evoke Pharma, Inc. -7.43 Million USD 10.565%
Flora Growth Corp. -50.35 Million USD 86.802%
Cyclo Therapeutics, Inc. -20.05 Million USD 66.854%
Evolus, Inc. -49.23 Million USD 86.501%
HUTCHMED (China) Limited 18.37 Million USD 136.168%
Amphastar Pharmaceuticals, Inc. 196.98 Million USD 103.374%
Akanda Corp. -10.05 Million USD 33.882%